Opponents of the medical device tax have a few celebrities on their side, perhaps newest among them former presidential candidate Herman Cain. Cain penned an anti-tax editorial last week for WSBRadio.com, where he's the host of a show that boasts the tag-line "Ask the Hermanator."
Apollo Endosurgery, Inc., a company focused on the development of devices that enable a new generation of endoscopic surgical procedures, announced that its OverStitch Endoscopic Suturing System has received the European Union's CE Mark. The company plans to immediately launch the system to...
Transvaginal Mesh Settlement Funding News: Legal-Bay To Increase Funding Amounts Up to $250K On Some Vaginal Mesh and Bladder Sling Recall CasesApril 2, 2013 5:00 am | by PR Newswire | News | Comments
ATLANTIC CITY, N.J., April 2, 2013 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that they have increased their funding amounts to $250K on a select few Transvaginal Mesh cases waiting for their settlement check.
Notice of Change of Meeting Schedule: April 25, 2013 Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory CommitteeApril 2, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Wednesday, February 27, 2013 (78 FR 13347). The meeting was shortened to one day, as it was later determined that in order to be more financially prudent all three topics could fit into one day.
C.R. Bard revealed a 1-2 punch today when it reported another loss in its patent infringement war with W.L. Gore and an adverse insurance decision that could cost it $25 million. The medical device company said in regulatory filings that the U.S. Patent & Trademark Office issued an initial finding in its reexamination of a Bard patent for a "Prosthetic vascular graft," known as the '135 patent.
Biomet said it plans to hold onto its dental business after all, having mulled divesting the unit over the past 10 months. Last June the privately held orthopedics giant said it was testing the waters of a possible sale or spinout for Biomet 3i.
Analysts at PricewaterhouseCoopers say that life sciences companies that are ready to evolve along with China's shifting landscape will be in the best position to capitalize on what's projected to become a $1 trillion healthcare market within the decade.
Abiomed said the 1st patient to receive its right-side heart pump, the Impella RP, as part of a clinical trial aimed at U.S. approval was implanted with the device in Philadelphia. The Danvers, Mass.-based medical device company said the patient was implanted with the Impella RP after implantation with another type of heart pump called a left ventricular assist device.
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. gave themselves until the end of May to hash out a deal over a criminal probe into ArthroCare's spinal business. It's the 3rd extension of a so-called tolling agreement between the Austin, Texas-based medical device company and the feds that lengthens the the statute of limitations on the investigation.
The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson's Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug. Invokana is a potential blockbuster drug that acts by reducing the amount of blood sugar that's normally stored in the liver, instead causing the body to excrete the excess sugar in urine.
Recent headlines are taking aim at robotic surgery, highlighting an increase in surgical complications and subsequent lawsuits. As the viability of the da Vinci Surgical System is called into question, Dr. David Samadi says one thing remains certain, "The surgeon, not the robot, is responsible for surgical outcomes."
Novotechnik, U.S. introduces the RSC3200 Series of Hall effect angle sensors designed for use in harsh environments and high reliability applications with redundant outputs and immunity to adverse environmental effects.
Molex Incorporated announced today its Projected Capacitive Touch Screens, which leverage existing Molex capacitive switch technology to deliver multi-touch functionality that is responsive and intuitive to operate.
BLACKFOOT, Idaho--(BUSINESS WIRE)--Apr 1, 2013--Bingham Memorial Hospital today announced it will be the first hospital in the Intermountain West Region to offer the new LINX procedure for patients suffering from Gastroesophageal Reflux Disease (GERD), a chronic disease allowing gastric fluid to...
Mokon’s line of Iceman Low Temperature chillers is now available with operating temperatures from -20°F to +20°F (-29°C to -7°C) and nominal capacities up to 12 Tons in both air and water-cooled condensing.